PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 6173293

Brain monoamine levels and E1 mouse convulsions.

M Hiramatsu
View original source ↗Export metadata ↓

Abstract

E1 mice had higher levels of brain dopamine (DA) and serotonin (5-HT) and a lower level of brain norepinephrine (NE) compared with the other strains of inbred mice. In the interictal stage of "stimulated" E1 mouse, the brain DA, NE and 5-HT levels were significantly lower compared with the non-stimulated E1 mouse. The administration of 5-hydroxytryptophan with MK486 markedly depressed the incidence of seizures in the E1 mouse. Evidence of abnormal DA, NE and 5-HT metabolism was found at the development age when the seizures became frequent. These results show that 5-HT may be closely related to the E1 mouse seizure susceptibility.

Explore related subjects

5-HydroxytryptophanAnimalsBrainDioxolesDopamineEvoked PotentialsFusaric AcidHydroxyindoleacetic AcidLevodopaMethyltyrosinesMiceMice, Inbred StrainsMice, Neurologic MutantsNeurotransmitter AgentsNorepinephrineReserpineSeizuresSerotoninalpha-MethyltyrosineJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Hiramatsu. 1981. Brain monoamine levels and E1 mouse convulsions.. https://doi.org/10.1111/j.1440-1819.1981.tb00224.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Dihydropteridine reductase deficiency: levodopa's long-term effectiveness without dyskinesia.

We report an adult patient lacking endogenous synthesis of monoamines (dopamine, serotonin, and catecholamines) due to a severe dihydropteridine reductase (DHPR) deficiency. With levodopa and 5-hydroxytryptophan (5HTP) supplementation, the patient exhibited moderate mental retardation, acute episodes of parkinsonism, and episodes of depression. Despite the use of levodopa from age 3 months, he exhibited no dyskinesia or dopaminergic cell loss as suggested by normal PET imaging of the dopamine transporter.

5-Hydroxytryptophan↗
PubMed2006

Anxiolytic effect of serotonin depletion in the novelty-induced hypophagia test.

RATIONALE: Relatively little is known about the neural mechanisms underlying anxiety in the novelty-induced hypophagia test, the only known anxiety test that is responsive to chronic but not acute or subchronic antidepressant treatment. OBJECTIVES: The goal of the present experiment was to characterize the role of serotonin in the ability of novelty to suppress feeding. MATERIALS AND METHODS: Pair-housed male Sprague-Dawley rats were trained to eat graham cracker crumbs individually in their home cage (15 min/day). After stable daily intakes were obtained, the animals were depleted of serotonin using 4-chloro-DL -phenylalanine (150 mg kg(-1) day(-1) x 2 days). Forty-eight hours later, central serotonin was restored by the administration of the peripheral L -aromatic amino acid decarboxylase inhibitor, benserazide (10 mg/kg), followed 15 min later with the immediate precursor of serotonin, 5-hydroxy-L -tryptophan (30 mg/kg). Thirty minutes later, the animals were given access to graham cracker crumbs in a novel environment. RESULTS: The animals demonstrated increased latencies to approach the food and reduced food intake in the novel environment. This effect was attenuated by serotonin depletion. Repletion of central serotonin restored the inhibitory response to novelty. The analysis of serotonin content in different brain regions confirmed that serotonin was depleted by greater than 90%, whereas the repletion treatment resulted in serotonin levels similar to nondepleted animals. CONCLUSIONS: Acute depletion of serotonin acts to reduce anxiety behavior as measured by an inhibitory anxiety response during exposure to novel stimuli. These findings are in agreement with the proposed general role for serotonin in behavioral inhibition and that reductions of serotonin facilitate the adoption of more active coping responses to stress.

5-Hydroxytryptophan↗
PubMed2006

Altered levels of serotonin in lymphoblasts derived from migraine patients.

We previously reported that dysfunctions in the autonomic nervous systems of patients with migraines occur not only in the brain, but throughout the whole body. Serotonin and neuropeptides are also known to have important roles in the pathophysiology of migraine. With this background in mind, we analyzed human lymphoblast cell lines from migraine with aura (MwA) patients to investigate the pathophysiology of migraine. The characteristics of these lymphoblasts and the involvement of the lymphoblasts in serotonin metabolism were examined. The lymphoblasts expressed serotonin receptors as well as some enzymes related to serotonin metabolism. The serotonin level in the MwA lymphoblasts was higher than that in the control cells. However, serotonin uptake into the lymphoblasts in MwA patients was similar to that in the control subjects. These findings suggest that lymphoblasts in MwA patients have altered levels of serotonin metabolism. Moreover, we propose that this lymphoblast cell system could serve as a novel modality for migraine research.

5-Hydroxytryptophan↗